Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that the U.S. Food and Drug ...

Solu Therapeutics, a company developing a new type of antibody drug, unveiled $41 million in financing on Wednesday for clinical testing of a therapy with the potential to bring a safer and more ...

BOSTON, Dec. 2, 2025 /PRNewswire/ -- Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today ...

The use of realia on disc might well have gone the same way as Syd Barrett's homemade attempts to capture the sounds of a live motorbike for his piece Rhamadan—into the cutting bin. But his ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. A startup working with Stanford University to combat the issue of antibiotic resistance has secured $1 ...

BOSTON--(BUSINESS WIRE)--Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate disease-driving cells, today announced the appointment of Philip J. Vickers, Ph.D., as ...

Solu is a computer that wants to rethink how users interact with their computer. It's described as an advanced cloud-linked computer that takes the worry of storage space, file backups, and software ...